11,508
Total Claims
$1.7M
Drug Cost
971
Beneficiaries
$1,730
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-88%
Opioid rate vs peers
0.3% vs 2.2% avg
+23%
Cost per patient vs peers
$1,730 vs $1,411 avg
+8%
Brand preference vs peers
11.5% vs 10.6% avg
Opioid Prescribing
0.3%
Opioid Rate
30
Opioid Claims
$179
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
89% generic
Brand: 1,312 claims · $1.5M
Generic: 10,063 claims · $207K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 226 | $391K |
| Sitagliptin Phosphate | 123 | $207K |
| Liraglutide | 47 | $140K |
| Mirabegron | 64 | $86K |
| Dulaglutide | 38 | $83K |
| Linagliptin | 40 | $62K |
| Insulin Glargine,hum.Rec.Anlog | 48 | $44K |
| Apixaban | 33 | $39K |
| Insulin Glargine,hum.Rec.Anlog | 49 | $39K |
| Sitagliptin Phos/Metformin Hcl | 27 | $35K |
| Denosumab | 18 | $31K |
| Semaglutide | 18 | $31K |
| Dapagliflozin Propanediol | 14 | $26K |
| Linaclotide | 19 | $23K |
| Insulin Glargine,hum.Rec.Anlog | 25 | $21K |
Prescribing Profile
Patient Profile
75
Avg Age
62%
Female
1.73
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data